Have a personal or library account? Click to login
Decreased activity and accelerated apoptosis of neutrophils in the presence of natural polyphenols Cover

Decreased activity and accelerated apoptosis of neutrophils in the presence of natural polyphenols

Open Access
|Nov 2012

References

  1. Adams M, Pacher T, Greger H, Bauer R. (2005). Inhibition of leukotriene biosynthesis by stilbenoids from Stemona species. J Nat Prod 68: 83-85.
  2. Aggarwal BB, Sung B. (2009). Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30: 85-94.
  3. Alarcon de la Lastra C, Villegas I. (2005). Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications. Mol Nutr Food Res 49: 405-430.
  4. Ambruso DR, Cusack N, Thurman G. (2004). NADPH oxidase activity of neutrophil specifi c granules: requirements for cytosolic components and evidence of assembly during cell activation. Mol Gen Metab 81: 313-321.
  5. Anonym. (2010). Resveratrol Monograph. Alter Med Rev 15: 152-158.
  6. Anonym. (2010). Pterostilbene Monograph. Alter Med Rev 15: 159-163.
  7. Burgos RA, Hidalgo MA, Figueroa CD, Conejeros I, Hancke JL. (2009). New potential targets to modulate neutrophil function in inflammation. MiniRev Med Chem 9: 153-168.
  8. Cascao R, Rosario HS, Fonseca JE. (2009). Neutrophils: warriors and commanders in immune mediated infl ammatory diseases. Acta Reumatol Port 34: 313-326.
  9. Cascao R, Rosario HS, Souto-Carneiro MM, Fonseca JE. (2010). Neutrophils in rheumatoid arthritis: More than simple fi nal eff ectors. Autoimmun Rev 9: 531-535.
  10. Cavallaro A, Ainis T, Bottari C, Fimiani V. (2003). Eff ect of resveratrol on some activities of isolated and in whole blood human neutrophils. Physiol Res 52: 555-562.
  11. Cichocki M, Paluszczak J, Szaefer H, Piechowiak A, Rimando AM, Baer-Dubowska W. (2008). Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoyl phorbol-13-acetate activated NFκB, AP-1, COX-2, and iNOS in mouse epidermis. Mol Nutr Food Res 52: 62-70.
  12. Derouet M, Thomas L, Moulding DA, Akgul C, Cross A, Moots RJ, Edwards SW. (2006). Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1. J Immunol 176: 957-965.
  13. Drabikova K, Jančinova V, Nosaľ R, Solik P, Murin J, Holomaňova D. (2006). On the antioxidant activity of carvedilol in human polymorphonuclear leukocytes in vitro and ex vivo. Neuroendocrinol Lett 27: 138-140.
  14. Drabikova K, Perečko T, Nosaľ R, Bauerova K, Poništ S, Mihalova D, Kogan G, Jančinova V. (2009). Glucomannan reduces neutrophil free radical production in vitro and in rats with adjuvant arthritis. Pharmacol Res 59: 399-403.
  15. Duffin R, Leitch AE, Fox S, Haslett C, Rossi AG. (2010). Targeting granulocyte apoptosis: mechanisms, models, and therapies. Immunol Rev 236: 28-40.
  16. Edwards SW, Hallett MB. (1997). Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol Today 18: 320-324.
  17. El-Benna J, Dang PMC, Perianin A. (2010). Peptide-based inhibitors of the phagocyte NADPH oxidase. Biochem Pharmacol 80: 778-785.
  18. Ennaciri J, Girard D. (2009). IL-4R (alpha), a new member that associates with Syk kinase: implication in IL-4-induced human neutrophil functions. J Immunol 183: 5261-5269.
  19. Fialkow L, Wang Y, Downey GP. (2007). Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Rad Biol Med 42: 153-164.
  20. Filep JG, El Kebir D. (2009). Neutrophil apoptosis: a target for enhancing the resolution of infl ammation. J Cell Biochem 108: 1039-1046.
  21. Hallett JM, Leitch AE, Riley NA, Duffi n R, Haslett C, Rossi AG. (2008). Novel pharmacological strategies for driving infl ammatory cell apoptosis and enhancing the resolution of infl ammation. Trends Pharmacol Sci 29: 250-257.
  22. Halliwell B, Whiteman M. (2004). Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Brit J Pharmacol 142: 231-255.10.1038/sj.bjp.0705776157495115155533
  23. Haricumar KB, Aggarwal BB. (2008). Resveratrol: a multitargeted agent for age-associated chronic diseses. Cell cycle 7: 1020-1035.
  24. Harmatha J, Zidek Z, Kmoničkova E, Šmidrkal J. (2011). Immunobiological properties of selected natural and chemically modified phenylpropanoids. Interdisc Toxicol 4: 5-10.
  25. Hu M, Du Q, Vancurova I, Lin X, Miller EJ, Simms HH, Wang P. (2005). Proapoptic effect of curcumin on human neutrophils: Activation of the p38 mitogen-activated protein kinase pathway. Crit Care Med 33: 2571-2578.
  26. Jagetia GC, Aggarwal BB. (2007). „Spicing up“of the immune system by curcumin. J Clin Immunol 27: 19-35.
  27. Jančinova V, Perečko T, Nosaľ R, Košťalova D, Bauerova K, Drabikova K. (2009). Decreased activity of neutrophils in the presence of diferuloylmethane (curcumin) involves protein kinase C inhibition. Eur J Pharmacol 612: 161-166.
  28. Jančinova V, Perečko T, Nosaľ R, Mihalova D, Bauerova K, Drabikova K. (2011). Pharmacological regulation of neutrophil activity and apoptosis. Contribution to new strategy for modulation of infl ammatory processes. Interdisc Toxicol 4: 101-104.
  29. Jančinova V, Perečko T, Drabikova K, Nosaľ R, Svitekova K. (2011a). Piceatannol, a natural analogue of resveratrol, inhibits oxidative burst of human neutrophils. Interdisc Toxicol 4: A35-A36.
  30. Jurenka JS. (2009). Anti-infl ammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev 14: 141-153.
  31. Karlsson A, Dahlgren C. (2002). Assembly and activation of the neutrophil NADPH oxidase in granule membranes. Antioxid Redox Signal 4: 49-60.
  32. Kim YH, Kwon HS, Kim DH, Cho HJ, Lee HS, Jun JG, Park JH, Kim JK. (2008). Piceatannol, a stilbene present in grapes, attenuates dextran sulfate sodium-induced colitis. Int Immunopharmacol 8: 1695-1702.
  33. Kohli P, Levy BD. (2009). Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol 158: 960-971.
  34. Kohnen S, Franck T, Van Antwerpen P, Boudjeltia KZ, Mouithys-Mickalad A, Deby C, Moguilevsky N, Deby-Dupont G, Lamy M, Serteyn D. (2007). Resveratrol inhibits the activity of equine neutrophil myeloperoxidase by a direct interaction with the enzyme. J Agric Food Chem 55: 8080-8087.
  35. Lee J, Jung E, Lim J, Lee J, Hur S, Kim SS, Lim S, Hyun CG, Kim YS, Park D. (2006). Involvement of nuclear factor-kappa B in the inhibition of pro-inflammatory mediators by pinosylvin. Planta Med 72: 801-806.
  36. Lonkar P, Dedon PC. (2011). Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer 128: 1999-2009.
  37. Luo HR, Loison F. (2008). Constitutive neutrophil apoptosis: mechanisms and regulation. Am J Hematol 83: 288-295.
  38. Nosaľ R, Perečko T, Jančinova V, Drabikova K, Harmatha J, Svitekova K. (2010). Suppression of oxidative burst in human neutrophils with the naturally occurring serotonin derivative isomer from Leuzea carthamoides. Neuroendocrinol Lett 31: 69-72.
  39. Nosaľ R, Perečko T, Jančinova V, Drabikova K, Harmatha J, Svitekova K. (2011). Naturally appearing N-feruloylserotonin isomers suppress oxidative burstof human neutrophils at the protein kinase C level. Pharmacol Rep 63: 790-798.
  40. Nussbaum G, Shapira L. (2011). How has neutrophil research improved our understanding of periodontal pathogenesis. J Clin Periodontol 38: 49-59.
  41. Park EJ, Ahn YH, Pyee JH, Park HJ, Chung HJ, Min HY, Hong JY, Kang YJ, Bae IK, Lee SK. (2005). Suppressive eff ects of pinosylvin, a natural stilbenoid, on cyclooxygenase-2 and inducible nitric oxide synthase and the growth inhibitor of cancer cells. Proc Amer Assoc Cancer Res 46: 176.
  42. Park EJ, Min HY, Chung HJ, Ahn YH, Pyee JH, Lee SK. (2011). Pinosylvin suppresses LPS-stimulated inducible nitric oxide synthase expression via the MyD88-independent, but TRIF-dependent downregulation of IRF-3 signaling pathway in mouse macrophage cells. Cell Physiol Biochem 27: 353-362.
  43. Paul S, Rimando AM, Lee HJ, Ji Y, Reddy BS, Suh N. (2009). Anti-inflammatory action of pterostilbene is mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells. Cancer Prev Res (Phila) 2: 650-657.
  44. Perečko T, Jančinova V, Drabikova K, Nosaľ R, Harmatha J. (2008). Structureefficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosylvin and pterostilbene. Neuroendocrinol Lett 29: 802-805.
  45. Perečko T, Drabikova K, Račkova L, Čiž M, Podborska M, Lojek A, Harmatha J, Šmidrkal J, Nosaľ R, Jančinova V. (2010). Molecular targets of the natural antioxidant pterostilbene: eff ect on protein kinase C, caspase-3 and apoposis in human neutrophils in vitro. Neuroendocrinol Lett 31: 84-90.
  46. Piga R, Naito Y, Kokura S, Handa O, Yoshikawa T. (2009). Inhibitory effect of serotonin derivatives on high glucose-induced adhesion and migration of monocytes on human aortic endothelial cells. Br J Nutr 102: 264-272.
  47. Piga R, Naito Y, Kokura S, Handa O, Yoshikawa T. (2010). Protective effect of serotonin derivatives on glucose-induced damage in PC12 rat pheochromocytoma cells. Br J Nutr 103: 25-31.
  48. Prasad NS, Raghavendra R, Lokesh BR, Naidu KA. (2004). Spice phenolics inhibit human PMNL 5-lipoxygenase. Prostaglandins Leukot Essent Fatty Acids 70: 521-528.
  49. Remsberg CM, Yańez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM. (2008). Pharmacometrics of Pterostilbene: Preclinical pharmacokinetics and metabolism, anticancer, antiinfl ammatory, antioxidant and analgesic activity. Phytother Res 22: 169-179.
  50. Richard N, Porath D, Radspieler A, Schwager J. (2005). Eff ects of resveratrol, piceatannol, tri-acetoxystilbene, and genistein on the inflammatory response of human peripheral blood leukocytes. Mol Nutr Food Res 49: 431-442.
  51. Robinson JM. (2009). Phagocytic leukocytes and reactive oxygen species. Histochem Cell Biol 131: 465-469.
  52. Rossi AG, Hallett JM, Sawatzki DA, Teixeira MM, Haslett C. (2007). Modulation of granulocyte apoptosis can infl uence the resolution of infl ammation. Biochem Soc Trans 35: 288-291.
  53. Roupe KA, Remsberg CM, Yanez JA, Davies NM. (2006). Pharmacometrics of stilbenes: Seguing towards the clinic. Curr Clin Pharmacol 1: 81-101.
  54. Sawatzky DA, Willoughby DA, Colville-Nash PR, Rossi AG. (2006). The involvement of the apoptosis-modulating proteins ERK 1/2, Bcl-xL and Bax in the resolution of acute infl ammation in vivo. Am J Pathol 168: 33-41.
  55. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O’Neill LAJ, Perretti M, Rossi AG, Wallace JL. (2007). Resolution of infl ammation: state of the art, defi nitions and terms. FASEB J 21: 325-332.
  56. Serhan CN, Yacoubian S, Yang R. (2008). Anti-infl ammatory and pro-resolving lipid mediators. Annu Rev Pathol 3: 279-312.
  57. Sheppard FR, Kelher MR, Moore EE, McLaughlin NJD, Banerjee A, Silliman CC. (2005). Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J Leukoc Biol 78: 1025-1042.
  58. Son PS, Park SA, Na HK, Jue DM, Kim S, Surh YJ. (2010). Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NFkappa B activation and cyclooxygenase-2 expression in human breast epithelial cells: cysteine 179 of IKKbeta as a potential target. Carcinognesis 31: 1442-1449.
  59. Srivastava RM, Singh S, Dubey SK, Misra K, Khar A. (2011). Immunomodulatory and therapeutic activity of curcumin. Int Immunopharmacol 11: 331-341.
  60. Takahashi R, Edashige K, Sato EF, Inoue M. (1991). Luminol chemiluminescence and active oxygen generation by activated neutrophils. Arch Biochem Biophys 285: 325-330.
  61. Witko-Sarsat V, Pederzoli-Ribeil M, Hirsh E, Sozzani S, Cassatella MA. (2011). Regulating neutrophil apoptosis: new players enter the game. Trends Immunol 32: 117-124.
  62. Wright HL, Moots RJ, Bucknall RC, Edwards SW. (2010). Neutrophil function in inflammation and infl ammatory diseases. Rheumatology 49: 1618-1631.
  63. Yasui K, Baba A. (2006). Therapeutic potential of superoxide dismutase (SOD) for resolution of infl ammation. Infl amm Res 55: 359-363.
DOI: https://doi.org/10.2478/v10102-012-0010-9 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 59 - 64
Published on: Nov 9, 2012
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2012 Viera Jančinová, Tomáš Perečko, Juraj Harmatha, Radomír Nosáľ, Katarína Drábiková, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.